Triomics to attempt to revolutionize clinical trials for cancer patients

May 14, 2024

Novo Nordisk Forges Million-Dollar Research Pacts with Flagship-Backed Biotechs for Advanced Cardiometabolic Solutions

January 9, 2024

Top 10 Infrastructure Priorities for AI-Driven Healthcare Enterprises

June 9, 2026

Must Read

Novartis Reports Positive Phase 3 Results for Rhapsido in Relapsing Multiple Sclerosis

September 2, 2026

ArsenalBio Lays Off 99 Employees and Shifts Focus to In Vivo CAR-T Programs

September 2, 2026

FDA Clears Jazz’s Ziihera for First-Line Treatment of HER2-Positive Gastroesophageal Cancer

August 31, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Novo Launches Late-Stage Trial of Lower-Dose Wegovy Pill for Weight Management

Oregon Study Finds Triple-Drug Regimen Kept Infant Macaques HIV-Free for One Year

Summit and Akeso Report Updated HARMONi Survival Data for Ivonescimab in Western NSCLC Patients

ARPA-H Awards Up to $160 Million for Personalized Genetic Medicine Development

Novartis Reports Positive Phase 3 Results for Rhapsido in Relapsing Multiple Sclerosis

Ambros and Werewolf Merge as Neridronate Advances in Phase 3 Trial for CRPS-1

Another late-stage victory for Tezspire is achieved by AstraZeneca and Amgen, this time in esophagitis

Despite a mid-stage failure, Bausch + Lomb moves a medication for dry eye condition to Phase 3

Roche Licenses Hanmi’s HM17321 Obesity Candidate in Deal Worth Up to $2.3 Billion

Leo Pharma Pens Mega Deal to Buy Tanabe’s Skin Disease Drug

PTC Therapeutics Acquires ST-920 Fabry Disease Gene Therapy Program From Sangamo

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Why AI Agents Will Become Every Pharmaceutical Employee’s Copilot

How Digital Twins Are Transforming Drug Development

Top 10 Digital Commercial Excellence Strategies

AI-Powered Protocol Design

Editorial Team

Takeda’s Qdenga Makes History as First Vaccine to Get the Nod in India

Editor Picks

Triomics to attempt to revolutionize clinical trials for cancer patients

Novo Nordisk Forges Million-Dollar Research Pacts with Flagship-Backed Biotechs for Advanced Cardiometabolic Solutions

Top 10 Infrastructure Priorities for AI-Driven Healthcare Enterprises

Must Read

Novartis Reports Positive Phase 3 Results for Rhapsido in Relapsing Multiple Sclerosis

ArsenalBio Lays Off 99 Employees and Shifts Focus to In Vivo CAR-T Programs

FDA Clears Jazz’s Ziihera for First-Line Treatment of HER2-Positive Gastroesophageal Cancer

Hot Topics

About Us

Follow Us